SCHEMBL4902923

SCHEMBL4902923

Cc1cc(Nc2cccc(-c3ccccn3)n2)ncc1-c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 3/20 0.44
ABL1 P00519 4/20 0.44
TGFBR1 P36897 3/20 0.43
MAPK14 Q16539 1/20 0.43
KARS1 Q15046 3/20 0.41
MEN1 O00255 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
ALPL P05186 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
PPP1CA P62136 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4894249 0.81 NPC1 (0.48) SQORTGFBR1MAPK14MEN1NPC1
SCHEMBL4899846 0.78 TDP1 (0.44) KARS1MEN1NPC1RAB9AKMT2A
Hydrochloric Acid SCHEMBL4901670 0.76 TP53 (0.47) MEN1NPC1RAB9AKMT2AALDH1A1
SCHEMBL4905155 0.76 GRM5 (0.47) TGFBR1KARS1MEN1NPC1RAB9A
SCHEMBL4896808 0.74 TP53 (0.41) ABL1TGFBR1MEN1NPC1RAB9A
SCHEMBL20919383 0.74 KDM4E (0.68) ABL1MEN1NPC1RAB9AKMT2A
SCHEMBL9491942 0.73 TGFBR1 (0.54) SQORTGFBR1MAPK14NPC1RAB9A
SCHEMBL4903188 0.72 KARS1 (0.64) ABL1KARS1MEN1NPC1RAB9A
Hydrochloric Acid SCHEMBL4904575 0.71 KARS1 (0.62) ABL1KARS1MEN1NPC1RAB9A
SCHEMBL4895714 0.71 TP53 (0.47) KARS1MEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 SQOR 253/4885ABL1 2194/4885TGFBR1 4493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.